Avanos Medical (NYSE:AVNS) and OceanTech Acquisitions I (NASDAQ:OTEC) Head-To-Head Contrast

OceanTech Acquisitions I (NASDAQ:OTEC) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability.

Institutional and Insider Ownership

15.3% of OceanTech Acquisitions I shares are owned by institutional investors. Comparatively, 93.8% of Avanos Medical shares are owned by institutional investors. 68.0% of OceanTech Acquisitions I shares are owned by company insiders. Comparatively, 2.9% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations for OceanTech Acquisitions I and Avanos Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OceanTech Acquisitions I	0	0	0	0	N/A
Avanos Medical	1	1	1	0	2.00

Avanos Medical has a consensus target price of $31.00, indicating a potential upside of 55.54%. Given Avanos Medical’s higher possible upside, analysts clearly believe Avanos Medical is more favorable than OceanTech Acquisitions I.

Earnings & Valuation

This table compares OceanTech Acquisitions I and Avanos Medical’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OceanTech Acquisitions I	N/A	N/A	$1.97 million	N/A	N/A
Avanos Medical	$820.00 million	1.14	$50.50 million	($0.78)	-25.55

Avanos Medical has higher revenue and earnings than OceanTech Acquisitions I.

Profitability

This table compares OceanTech Acquisitions I and Avanos Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OceanTech Acquisitions I	N/A	-23.80%	-2.17%
Avanos Medical	-4.61%	5.49%	4.01%

Summary

Avanos Medical beats OceanTech Acquisitions I on 7 of the 9 factors compared between the two stocks.

About OceanTech Acquisitions I

OceanTech Acquisitions I Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization/similar business combination with one/more businesses in the leisure marine, yachting, and superyachting industries. OceanTech Acquisitions I Corp. was incorporated in 2021 and is based in New York, New York.

About Avanos Medical

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy and OrthogenRx's knee osteoarthritis pain relief injection products. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.